Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.19 USD | +1.45% | +1.95% | -23.82% |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- MRKR Stock
- Revisions Marker Therapeutics, Inc.